Article

The Role of Intellectual Property Rights on Access to Medicines in the WHO African Region: 25 Years After the TRIPS Agreement

2021-01-21

Abstract excerpt

<h4>Background: </h4> It is now 25 years since the adoption of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the same concerns raised during its negotiations such as high prices of medicines, market exclusivity and delayed market entry for generics remain relevant as highlighted recently by the Ebola and COVID-19 pandemics. The World Health Organization’s (WHO) mandate to work...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 76a2f8a7-094f-5972-8505-c5ebf5ac3109
DOI: 10.21203/rs.3.rs-62959/v4

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Role of Intellectual Property Rights on Access to Medicines in the WHO African Region: 25 Years After the TRIPS AgreementDOI 10.21203/rs.3.rs-62959/v4Read

The Intellectual Property of COVID-19Semantic proximity Read

Beyond Traditional IP: Addressing Regulatory BarriersSemantic proximity Read

Operationalisation of the African Medicines Agency: Retrospective evaluation of the continental centralized pilot procedure – timelines to recommendation and national registration decisionsSemantic proximity Read

Initiatives to Promote Access to Medicines After the Publication of National Policy on Comprehensive Care of People With Rare Diseases in BrazilSemantic proximity Read

Trends in the Utilization of Medicines Sold in the Private Sector Post- Registration in South Africa and the Implications for Similar CountriesSemantic proximity Read

Addressing Exclusivity Issues During the COVID-19 Pandemic and BeyondSemantic proximity Read

Revisiting Canada’s Access to Medicines Regime in Response to COVID-19: A Review of the Legislation and its Underlying ObjectivesSemantic proximity Read

Harnessing Private Sector Engagement for Sustainable Vaccine and Pharmaceutical Manufacturing in Africa: A Qualitative Analysis of Multistakeholder DeliberationsSemantic proximity Read

Compelling Trade Secret TransfersSemantic proximity Read

Global Patterns in Access and Benefit-Sharing: A Comprehensive Review of National PoliciesSemantic proximity Read

Avoiding the TRIPS Trap: A Path to Domestic Disclosure of Clinical Drug Data Consistent with International NormsSemantic proximity Read

South African patenting trends based on the European Patent Office (EPO)’s worldwide patent statistical database (PATSTAT)Semantic proximity Read